Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibitor epidemiology and genetic-related risk factors in people with haemophilia from Côte d'Ivoire.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Jan 2020

Lambert Catherine, Lannoy Nathalie, Meité N'Dogomo, Sanogo Ibrahima, Eeckhoudt Stéphane, Hermans Cedric

Abstract excerpt

INTRODUCTION: In Sub-Saharan Africa, inhibitor prevalence data in people with haemophilia (PWH) are scarce, as are data on genetic or treatment-related risk factors. AIMS AND METHODS: We performed a prospective study on PWH from Côte d'Ivoire to collect data into inhibitor prevalence, create a database of haemophilia genotypes, establish correlations between inhibitor presence and genetic variants identified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Cote d'Ivoire

Share to Hemophilia A

Share to Infant

Share to Risk Factors

Share to Young Adult

Source

Identifiers

PMID: 31829478
DOI: 10.1111/hae.13902

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibitor epidemiology and genetic-related risk factors in people with haemophilia from Côte d'Ivoire.PMID 31829478Read ↗

Genetic risk factors for inhibitors in haemophilia A.Semantic proximity Read ↗

Genetic variant detection in a South African haemophilia B population.Semantic proximity Read ↗

HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdatasetSemantic proximity Read ↗

Relationship between mutations in severe hemophilia A and risk of inhibitor development: A large single-center study.Semantic proximity Read ↗

Unearthing the genotype-inhibitor phenotype association in severe haemophilia A: A north Indian cohort study.Semantic proximity Read ↗

Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients.Semantic proximity Read ↗

Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet studySemantic proximity Read ↗

Treatment burden, haemostatic strategies and real world inhibitor screening practice in non-severe haemophilia A.Semantic proximity Read ↗

Mutational landscape, inhibitor development, and health-care burden in non-severe haemophilia A: A single-centre Australian experience.Semantic proximity Read ↗

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.Semantic proximity Read ↗

Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States.Semantic proximity Read ↗

Factor VIII mutations and inhibitor formation in a southern Brazilian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.